Renalytix Plc (RENXF)
OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
At close: Feb 11, 2026
Renalytix Market Cap
Renalytix has a market cap or net worth of $24.11 million as of February 12, 2026. Its market cap has decreased by -44.38% in one year.
Market Cap
24.11M
Enterprise Value
28.68M
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 24.11M, a decrease of -71.46%. That is a compound annual growth rate of -15.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 24.60M | -29.12% |
| Dec 31, 2025 | 34.70M | -22.15% |
| Dec 31, 2024 | 44.57M | 125.93% |
| Dec 29, 2023 | 19.73M | -69.84% |
| Dec 30, 2022 | 65.42M | -89.22% |
| Dec 31, 2021 | 607.05M | 26.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revium Rx. | 91.09M |
| Vaso Corporation | 31.03M |
| Veri Medtech Holdings | 20.00M |
| CareView Communications | 13.51M |
| Pharma-Bio Serv | 13.06M |
| BioRegenx | 12.50M |
| Resilient Healthcare | 11.55M |
| DATATRAK International | 10.58M |